Does TENOFOVIR ALAFENAMIDE Cause Hepatic function abnormal? 18 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 18 reports of Hepatic function abnormal have been filed in association with TENOFOVIR ALAFENAMIDE (VEMLIDY). This represents 0.6% of all adverse event reports for TENOFOVIR ALAFENAMIDE.
18
Reports of Hepatic function abnormal with TENOFOVIR ALAFENAMIDE
0.6%
of all TENOFOVIR ALAFENAMIDE reports
1
Deaths
10
Hospitalizations
How Dangerous Is Hepatic function abnormal From TENOFOVIR ALAFENAMIDE?
Of the 18 reports, 1 (5.6%) resulted in death, 10 (55.6%) required hospitalization, and 2 (11.1%) were considered life-threatening.
Is Hepatic function abnormal Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TENOFOVIR ALAFENAMIDE. However, 18 reports have been filed with the FAERS database.
What Other Side Effects Does TENOFOVIR ALAFENAMIDE Cause?
Death (217)
Product dose omission issue (153)
Off label use (96)
Drug ineffective (93)
Fatigue (92)
Headache (71)
Product dose omission (69)
Intentional dose omission (67)
Product use issue (67)
Nausea (64)
What Other Drugs Cause Hepatic function abnormal?
NIVOLUMAB (1,131)
PEMBROLIZUMAB (1,079)
METHOTREXATE (1,054)
CABOZANTINIB S-MALATE (912)
CYCLOPHOSPHAMIDE (824)
BEVACIZUMAB (769)
PACLITAXEL (603)
LENVATINIB (528)
ATORVASTATIN (520)
CYCLOSPORINE (508)
Which TENOFOVIR ALAFENAMIDE Alternatives Have Lower Hepatic function abnormal Risk?
TENOFOVIR ALAFENAMIDE vs TENOFOVIR DISOPROXIL
TENOFOVIR ALAFENAMIDE vs TEPLIZUMAB-MZWV
TENOFOVIR ALAFENAMIDE vs TEPOTINIB
TENOFOVIR ALAFENAMIDE vs TEPROTUMUMAB
TENOFOVIR ALAFENAMIDE vs TEPROTUMUMAB-TRBW